首页> 外文OA文献 >Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine
【2h】

Secretory IgA-mediated protection against V. cholerae and heat-labile enterotoxin-producing enterotoxigenic Escherichia coli by rice-based vaccine

机译:基于水稻的疫苗的分泌型IgA介导的霍乱弧菌和不耐热产肠毒素的产肠毒素大肠杆菌的保护作用

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Cholera and enterotoxigenic Escherichia coli (ETEC) are among the most common causes of acute infantile gastroenteritis globally. We previously developed a rice-based vaccine that expressed cholera toxin B subunit (MucoRice-CTB) and had the advantages of being cold chain–free and providing protection against cholera toxin (CT)–induced diarrhea. To advance the development of MucoRice-CTB for human clinical application, we investigated whether the CTB-specific secretory IgA (SIgA) induced by MucoRice-CTB gives longstanding protection against diarrhea induced by Vibrio cholerae and heat-labile enterotoxin (LT)–producing ETEC (LT-ETEC) in mice. Oral immunization with MucoRice-CTB stored at room temperature for more than 3 y provided effective SIgA-mediated protection against CT- or LT-induced diarrhea, but the protection was impaired in polymeric Ig receptor–deficient mice lacking SIgA. The vaccine gave longstanding protection against CT- or LT-induced diarrhea (for ≥6 months after primary immunization), and a single booster immunization extended the duration of protective immunity by at least 4 months. Furthermore, MucoRice-CTB vaccination prevented diarrhea in the event of V. cholerae and LT-ETEC challenges. Thus, MucoRice-CTB is an effective long-term cold chain–free oral vaccine that induces CTB-specific SIgA-mediated longstanding protection against V. cholerae– or LT-ETEC–induced diarrhea.
机译:霍乱和产肠毒素的大肠杆菌(ETEC)是全球急性婴儿胃肠炎的最常见原因。我们以前曾开发过一种基于水稻的疫苗,该疫苗可表达霍乱毒素B亚基(MucoRice-CTB),并具有无冷链优势和针对霍乱毒素(CT)引起的腹泻的保护作用。为促进MucoRice-CTB在人类临床应用中的开发,我们调查了MucoRice-CTB诱导的CTB特异性分泌型IgA(SIgA)是否长期抵御霍乱弧菌和产生热不稳定肠毒素(LT)的ETEC引起的腹泻(LT-ETEC)在小鼠中。在室温下保存超过3年的MucoRice-CTB口服免疫可提供有效的SIgA介导的针对CT或LT引起的腹泻的保护作用,但对缺乏SIgA的聚合性Ig受体缺陷型小鼠的保护作用减弱。该疫苗对CT或LT引起的腹泻提供了长期保护(一次免疫后≥6个月),一次加强免疫将保护性免疫的持续时间延长了至少4个月。此外,在霍乱弧菌和LT-ETEC攻击的情况下,MucoRice-CTB疫苗预防了腹泻。因此,MucoRice-CTB是一种有效的长期无冷链口服疫苗,可诱导CTB特异性SIgA介导的长期保护,抵抗霍乱弧菌或LT-ETEC引起的腹泻。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号